Want to see HALO full AI Analyst Report?
Halozyme (HALO) Ratios
Halozyme Ratios
HALO's free cash flow for Q2 2026 was $236.72M. For the 2026 fiscal year, HALO's free cash flow was decreased by $-4.17M and operating cash flow was $240.89M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.66 | 7.80 | 6.64 | 5.65 | 7.91 |
| Quick Ratio | 3.66 | 6.78 | 5.50 | 4.88 | 7.45 |
| Cash Ratio | 0.76 | 0.83 | 1.05 | 1.79 | 1.01 |
| Solvency Ratio | 0.16 | 0.31 | 0.22 | 0.15 | 0.45 |
| Operating Cash Flow Ratio | 3.68 | 3.44 | 3.45 | 1.84 | 2.56 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 18.01 | 3.35 |
| Net Current Asset Value | $ -1.65B | $ -614.32M | $ -903.04M | $ -932.70M | $ 18.81M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.85 | 0.73 | 0.86 | 0.82 | 0.79 |
| Debt-to-Equity Ratio | 43.89 | 4.14 | 17.89 | 8.87 | 4.45 |
| Debt-to-Capital Ratio | 0.98 | 0.81 | 0.95 | 0.90 | 0.82 |
| Long-Term Debt-to-Capital Ratio | 0.98 | 0.81 | 0.95 | 0.90 | 0.80 |
| Financial Leverage Ratio | 51.73 | 5.67 | 20.68 | 10.85 | 5.61 |
| Debt Service Coverage Ratio | 23.34 | 30.04 | 20.53 | 8.87 | 4.26 |
| Interest Coverage Ratio | 44.28 | 30.48 | 17.99 | 15.79 | 36.66 |
| Debt to Market Cap | 0.27 | 0.25 | 0.31 | 0.19 | 0.16 |
| Interest Debt Per Share | 18.03 | 12.02 | 11.51 | 11.13 | 6.29 |
| Net Debt to EBITDA | 3.51 | 2.12 | 3.06 | 4.03 | 2.93 |
| Profitability Margins | |||||
| Gross Profit Margin | 83.62% | 84.30% | 76.80% | 78.90% | 81.64% |
| EBIT Margin | 34.73% | 56.65% | 44.27% | 40.28% | 57.76% |
| EBITDA Margin | 41.03% | 64.66% | 54.50% | 47.80% | 58.43% |
| Operating Profit Margin | 57.47% | 54.32% | 40.71% | 40.53% | 62.24% |
| Pretax Profit Margin | 33.43% | 54.87% | 42.01% | 37.71% | 56.06% |
| Net Profit Margin | 22.69% | 43.74% | 33.96% | 30.62% | 90.84% |
| Continuous Operations Profit Margin | 22.69% | 43.74% | 33.96% | 30.62% | 90.84% |
| Net Income Per EBT | 67.87% | 79.71% | 80.84% | 81.20% | 162.04% |
| EBT Per EBIT | 58.17% | 101.03% | 103.19% | 93.04% | 90.07% |
| Return on Assets (ROA) | 12.55% | 21.52% | 16.25% | 10.98% | 36.46% |
| Return on Equity (ROE) | 649.18% | 122.06% | 336.00% | 119.04% | 204.47% |
| Return on Capital Employed (ROCE) | 34.18% | 28.66% | 20.83% | 15.64% | 27.95% |
| Return on Invested Capital (ROIC) | 23.20% | 22.84% | 16.84% | 12.60% | 25.62% |
| Return on Tangible Assets | 32.89% | 35.67% | 33.38% | 22.82% | 36.46% |
| Earnings Yield | 3.93% | 7.32% | 5.78% | 2.60% | 7.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.16 | 3.29 | 3.54 | 2.86 | 4.87 |
| Payables Turnover | 10.95 | 15.55 | 16.28 | 7.87 | 52.83 |
| Inventory Turnover | 1.30 | 1.12 | 1.51 | 1.39 | 1.51 |
| Fixed Asset Turnover | 17.00 | 13.53 | 11.06 | 8.74 | 50.41 |
| Asset Turnover | 0.55 | 0.49 | 0.48 | 0.36 | 0.40 |
| Working Capital Turnover Ratio | 1.75 | 1.29 | 1.34 | 0.93 | 0.94 |
| Cash Conversion Cycle | 363.54 | 412.22 | 322.79 | 343.75 | 309.68 |
| Days of Sales Outstanding | 115.33 | 110.89 | 103.09 | 127.77 | 74.90 |
| Days of Inventory Outstanding | 281.56 | 324.80 | 242.12 | 262.34 | 241.69 |
| Days of Payables Outstanding | 33.34 | 23.47 | 22.42 | 46.36 | 6.91 |
| Operating Cycle | 396.88 | 435.69 | 345.21 | 390.11 | 316.59 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.44 | 3.78 | 2.95 | 1.75 | 2.13 |
| Free Cash Flow Per Share | 5.38 | 3.69 | 2.83 | 1.72 | 2.12 |
| Dividend Paid and CapEx Coverage Ratio | 93.48 | 44.79 | 25.41 | 49.92 | 205.52 |
| Capital Expenditure Coverage Ratio | 93.48 | 44.79 | 25.41 | 49.92 | 205.52 |
| Operating Cash Flow Coverage Ratio | 0.30 | 0.32 | 0.26 | 0.16 | 0.34 |
| Operating Cash Flow to Sales Ratio | 0.47 | 0.47 | 0.47 | 0.36 | 0.68 |
| Free Cash Flow Yield | 7.99% | 7.72% | 7.66% | 3.02% | 5.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 25.49 | 13.66 | 17.32 | 38.52 | 14.04 |
| Price-to-Sales (P/S) Ratio | 5.77 | 5.97 | 5.88 | 11.80 | 12.76 |
| Price-to-Book (P/B) Ratio | 165.22 | 16.67 | 58.18 | 45.86 | 28.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.51 | 12.95 | 13.06 | 33.09 | 18.98 |
| Price-to-Operating Cash Flow Ratio | 12.38 | 12.66 | 12.55 | 32.43 | 18.89 |
| Price-to-Earnings Growth (PEG) Ratio | -1.04 | 0.21 | 0.39 | -0.80 | 0.07 |
| Enterprise Value Multiple | 17.58 | 11.35 | 13.84 | 28.71 | 24.76 |
| Enterprise Value | 10.07B | 7.45B | 6.26B | 9.06B | 6.41B |
| EV to EBITDA | 17.58 | 11.35 | 13.84 | 28.71 | 24.76 |
| EV to Sales | 7.21 | 7.34 | 7.55 | 13.72 | 14.47 |
| EV to Free Cash Flow | 15.63 | 15.91 | 16.76 | 38.50 | 21.52 |
| EV to Operating Cash Flow | 15.46 | 15.56 | 16.10 | 37.73 | 21.42 |
| Tangible Book Value Per Share | -12.63 | -3.59 | -6.11 | -5.74 | 1.40 |
| Shareholders’ Equity Per Share | 0.41 | 2.87 | 0.64 | 1.24 | 1.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.32 | 0.20 | 0.19 | 0.19 | -0.62 |
| Revenue Per Share | 11.65 | 8.01 | 6.29 | 4.82 | 3.15 |
| Net Income Per Share | 2.64 | 3.50 | 2.13 | 1.48 | 2.86 |
| Tax Burden | 0.68 | 0.80 | 0.81 | 0.81 | 1.62 |
| Interest Burden | 0.96 | 0.97 | 0.95 | 0.94 | 0.97 |
| Research & Development to Revenue | 0.06 | 0.08 | 0.09 | 0.10 | 0.08 |
| SG&A to Revenue | 0.15 | 0.15 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 |
| Income Quality | 2.06 | 1.08 | 1.38 | 1.19 | 0.74 |
Currency in USD